The Structured Advocacy Collective is a known if minor player in GLMZ's civil-legal scene — they file complaints, they publish reports, they occasionally win small procedural victories against corporate medical programs. Their posting is careful and specific: they want records, not destruction, and they've specified that patient safety is a hard constraint. The pay is solid for a B-tier job. The brief reads like it was written by a lawyer.

The Calumet Cohort is 340 people from the Gray Zone 11 and 12 who enrolled in a chronic pain study after an industrial filtration accident left a significant percentage of the local population with degenerative nerve damage. Meridian Wellness Group promised treatment. What they delivered was an extended observational study — they catalogued the progression of the damage and tested proprietary compounds that never left trial phase. Participants signed consent forms that most of them couldn't parse. The records the Collective wants contain dosage logs, adverse event reports that were never filed with any oversight body, and correspondence between Meridian's clinical director and the company's litigation team. The Collective intends to publish. Meridian knows something is coming and has already begun the legal process of reclassifying the study data as proprietary research under trade secret protections. The audit window closing is not incidental — it's a designed deadline.